News und Analysen
Os Therapies Posts Wider Loss in Q2
Os Therapies (NYSEMKT:OSTX), a clinical-stage biotechnology company focused on immunotherapies for rare pediatric cancers, released earnings for Q2 2025 on August 19, 2025. The most important news
Home Depot Sales Up 5 Percent
Home Depot (NYSE:HD), the world’s largest home improvement retailer, delivered its earnings results for the second quarter of fiscal 2025 on August 19, 2025. The headline news was GAAP revenue
XP Inc Reports Record Q2 Profit
XP(NASDAQ:XP) reported second quarter 2025 results on Aug. 18, 2025, delivering record net income of BRL1.321 billion, up 18% year over year, and a return on equity of 24.4%. Total client assets
Flexsteel EPS Jumps 67 Percent
Flexsteel Industries (NASDAQ:FLXS), a manufacturer of residential upholstered furniture, reported results for the quarter ended June 30, 2025, on Aug. 18, 2025. The headline news was a clear beat on
Blink Charging Reports 38 Percent Gain
Blink Charging (NASDAQ:BLNK), a provider of electric vehicle (EV) charging equipment and services, reported its second quarter results on August 18, 2025. The headline news from the earnings release
Palo Alto Networks Revenue Jumps in Q4
Palo Alto Networks (NASDAQ:PANW), a leading global cybersecurity provider, reported its fiscal fourth quarter 2025 financial results on August 18, 2025. The company delivered results that were well
Duos Technologies Q2 Revenue Jumps 280%
Duos Technologies Group (NASDAQ:DUOT), a provider of machine vision, artificial intelligence, and edge computing solutions, Duos Technologies Group announced its second-quarter 2025 earnings in
1 Stock Down 40% This Year to Buy and Hold
Novo Nordisk (NYSE: NVO) first earned U.S. approval for its now-famous weight management medicine Wegovy in June 2021. That marked the beginning of a strong run for the company on the stock market
Where Will Apple Stock Be in 5 Years?
Apple (NASDAQ: AAPL) stock has been one of the best-ever investments on the market, crushing the market over several decades. Consider how much money you'd have today if you'd invested $10,000 in
Applied Materials Sets Revenue Record
Applied Materials(NASDAQ:AMAT) reported third-quarter fiscal 2025 results on August 14, 2025, delivering record quarterly revenue of $7.3 billion (up 8% year over year), record non-GAAP earnings per
Eledon Posts Narrower Loss in Q2
Eledon Pharmaceuticals (NASDAQ:ELDN), a biotechnology company focused on developing novel therapies for organ and cell transplantation as well as amyotrophic lateral sclerosis (ALS), issued its
Applied Materials Posts 8% Gain
Applied Materials (NASDAQ:AMAT), a leading supplier of materials engineering solutions for the semiconductor and display industries, reported its fiscal third-quarter results on Aug. 14, 2025. The
Strattec Security Posts 6 Percent Gain
Strattec Security (NASDAQ:STRT), a leading designer and manufacturer of mechanical and electronic locks and access control products for the automotive industry, released its fourth quarter fiscal
RenovoRx Revenue Jumps 28 Percent in Q2
RenovoRx (NASDAQ:RNXT), a medical technology company focused on targeted cancer therapy delivery, reported earnings on August 14, 2025. As sales of its RenovoCath device grew to $422,000 (GAAP)
Swk Posts 77% Profit Jump in Fiscal Q2
SWK (NASDAQ:SWKH), a specialty finance company targeting the healthcare sector, announced its second quarter 2025 results on August 14, 2025. The most notable headline is that its non-GAAP adjusted
Phio Posts Wider Loss in Fiscal Q2
Phio Pharmaceuticals (NASDAQ:PHIO), a biotechnology company developing gene-silencing therapies for cancer, released its second quarter 2025 results on August 14, 2025. The quarter’s key news
Talphera Cuts Expenses 14 Percent
Talphera (NASDAQ:TLPH), a specialty pharmaceutical company developing therapies for medically supervised hospital settings, reported its second quarter 2025 results on August 14, 2025. The company
Arcadia Biosciences Sales Up 11 Percent
Arcadia Biosciences (NASDAQ:RKDA), a consumer wellness beverage company known for the Zola coconut water brand, released its second quarter results on August 14, 2025. The company reported GAAP
Plus Therapeutics Posts Q2 Profit Jump
Plus Therapeutics (NASDAQ:PSTV), a clinical-stage biotech focused on radiotherapeutics and diagnostics for central nervous system cancers, reported its second quarter 2025 results on August 14
Annexon Narrows Loss in Fiscal Q2
Annexon (NASDAQ:ANNX), a clinical-stage biopharmaceutical company developing therapies for serious autoimmune and neurodegenerative diseases, released its second quarter 2025 financial results on
bioAffinity Misses Q2 Revenue Target
bioAffinity Technologies (NASDAQ:BIAF), a biotechnology company focused on noninvasive diagnostics and cancer therapeutics, reported results for Q2 2025 on August 14, 2025. The most significant news
Reading Revenue Jumps 29% in Fiscal Q2
Reading International (NASDAQ:RDI), an operator of cinemas and real estate properties across the United States, Australia, and New Zealand, reported its second quarter fiscal 2025 results on August
P3 Health Partners Posts Q2 Revenue Drop
P3 Health Partners (NASDAQ:PIII), a physician-led healthcare group focused on value-based care for Medicare Advantage members, reported results for Q2 FY2025 on August 14, 2025. The most notable
Celcuity Expenses Jump 81 Percent
Celcuity (NASDAQ:CELC), a clinical-stage biotechnology company developing targeted therapies for cancer, released its second quarter 2025 earnings on August 14, 2025. The highlight was topline Phase
Co-Diagnostics Sales Plunge 93 Percent
Co-Diagnostics (NASDAQ:CODX), a diagnostics technology company focused on infectious disease testing, announced its Q2 2025 results on August 14, 2025. GAAP EPS loss of $0.23 was better than